Cite
HARVARD Citation
Sokolove, J. et al. (n.d.). AB0274 Impact of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titre on Efficacy Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab: 2-Year Results from the Ample Trial. Annals of the rheumatic diseases. pp. 983-984. [Online].